pcDNA3.1-HA AKT1 Citations (3)

Originally described in: PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis.
Lee MS, Jeong MH, Lee HW, Han HJ, Ko A, Hewitt SM, Kim JH, Chun KH, Chung JY, Lee C, Cho H, Song J Nat Commun. 2015 Jul 17;6:7769. doi: 10.1038/ncomms8769. PubMed Journal

Articles Citing pcDNA3.1-HA AKT1

Showing 1 to 3 of 3 entries

Show entries

Search table:

Articles
Substrate preference of protein kinase B isoforms can vary depending on the cell line. Palma MS, Perez SR, Husain A, Bhandari D. PLoS One. 2024 Mar 19;19(3):e0298322. doi: 10.1371/journal.pone.0298322. eCollection 2024. PubMed
Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. Han X, Mei Y, Mishra RK, Bi H, Jain AD, Schiltz GE, Zhao B, Sukhanova M, Wang P, Grigorescu AA, Weber PC, Piwinski JJ, Prado MA, Paulo JA, Stephens L, Anderson KE, Abrams CS, Yang J, Ji P. J Clin Invest. 2023 Mar 15;133(6):e159638. doi: 10.1172/JCI159638. PubMed
Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells. Chen ZY, Li J, Zhu SD, Li ZD, Yu JL, Wu J, Zhang C, Zeng LH. Exp Ther Med. 2022 Mar;23(3):209. doi: 10.3892/etm.2022.11132. Epub 2022 Jan 7. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.